-
Sector Analysis
GLP-1R Agonists - Label Extensions/Drug Repurposing - Market Overview, Trends, Pricing, Pipeline Analysis, Future Players, Opportunities and Challenges
This report is a market overview of GLP-1R agonists, focusing on their potential repurposing and label expansions in diseases outside type 2 diabetes and obesity. The potential of GLP-1RAs is based on their insulin sensitization and anti-inflammatory properties. GLP-1RAs are being investigated in different diseases in the metabolic, neurologic, and cardiologic markets. Novo Nordisk and Eli Lilly are currently the major players in the GLP-1RA space, but opportunity remains for new entrants.
-
Product Insights
Thrombocytopenia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Thrombocytopenia - Global Clinical Trials Review, 2025" provides an overview of Thrombocytopenia Clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Atopic Dermatitis (Atopic Eczema)Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025" provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Duchenne Muscular Dystrophy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025" provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Global Clinical Trials Review, 2025" provides an overview of Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers...
-
Product Insights
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2025" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Graft Versus Host Disease (GVHD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025" provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2025" provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Aplastic Anemia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Aplastic Anemia - Global Clinical Trials Review, 2025" provides an overview of Aplastic Anemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuropathic Pain (Neuralgia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025" provides an overview of Neuropathic Pain (Neuralgia) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuropathic Pain (Neuralgia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.